Anil Bajnath, MD, MBA, IFMCP, ABAARMEmerging research is uncovering connections between multiple sclerosis, the gut microbiome, genetics, and immune function. Explore what these findings could mean for the future of precision medicine.
Discover how global genomics initiatives are expanding precision medicine through diverse population data, large-scale sequencing, disease risk prediction, rare disease research, and advances in personalized healthcare.
Liquid Biopsy 2.0 is moving beyond cancer. Discover how circulating biomarkers, cell-free DNA, RNA, and extracellular vesicles could transform disease detection, monitoring, and the future of precision medicine.
Explore how genetics and environmental factors work together to shape disease risk, and discover how precision medicine integrates genomic, lifestyle, and environmental data for personalized healthcare.
Explore how CRISPR gene editing is transforming precision medicine by enabling targeted DNA modifications for inherited diseases, cancer treatment, and regenerative medicine while addressing ethical challenges.
Explore how precision public health integrates genomics, epidemiology, and data science to improve disease prevention, population health, and personalized public health strategies.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.
